Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.
600 mg do not crush, chew, or break extended-release tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours. children under 12 years of age: do not use 1200 mg do not crush, chew, or break extended-release tablet ...
store between 20° to 25°C (68° to 77°F)
Active ingredient (in each extended-release tablet)
Guaifenesin 600 mg
Active ingredient (in each extended-release tablet)
Guaifenesin 1200 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
600 mg
1200 mg
carbomer, colloidal silicon dioxide, FD&C blue #1 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone and talc
1-877-835-5472 You may also report side effects to this phone number.
Distributed by:
Amneal Pharmaceuticals LLC
Bridgewater, NJ 08807
Rev. 10-2024-01
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 310621 | guaiFENesin 1200 MG 12HR Extended Release Oral Tablet | PSN | 12 |
| 636522 | guaiFENesin 600 MG 12HR Extended Release Oral Tablet | PSN | 12 |
| 310621 | 12 HR guaifenesin 1200 MG Extended Release Oral Tablet | SCD | 12 |
| 636522 | 12 HR guaifenesin 600 MG Extended Release Oral Tablet | SCD | 12 |
| 310621 | guaifenesin 1200 MG 12 HR Extended Release Oral Tablet | SY | 12 |
| 636522 | guaifenesin 600 MG 12 HR Extended Release Oral Tablet | SY | 12 |
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65162-036-02 | Guaifenesin | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 12 | |
| 65162-036-02 | Guaifenesin | 10 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 10 | 12 | |
| 65162-036-03 | Guaifenesin | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 12 | |
| 65162-036-03 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 65162-036-06 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 65162-036-06 | Guaifenesin | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 12 | |
| 65162-037-03 | Guaifenesin | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 12 | |
| 65162-037-03 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 65162-037-06 | Guaifenesin | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 65162-037-06 | Guaifenesin | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 12 | |
| 65162-037-28 | Guaifenesin | 14 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 14 | 12 | |
| 65162-037-28 | Guaifenesin | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 12 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65162-036 | GUAIFENESIN TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS LLC] | 12 | Current NDC, Legacy NDC, 6 package rows | 20241027_ad67e6fd-a68f-44db-9718-84a2cef86e09.zip |
| 65162-037 | GUAIFENESIN TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS LLC] | 12 | Current NDC, Legacy NDC, 6 package rows | 20241027_ad67e6fd-a68f-44db-9718-84a2cef86e09.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 65162-036 | 65162-036-02, 65162-036-03, 65162-036-06 |
| 65162-037 | 65162-037-28, 65162-037-03, 65162-037-06 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207342-001 | GUAIFENESIN | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | ||
| A207342-002 | GUAIFENESIN | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Guaifenesin | GUAIFENESIN | Amneal Pharmaceuticals LLC | ad67e6fd-a68f-44db-9718-84a2cef86e09 | 2024-10-07 | Warnings | 65162-036-03 65162-037-03 65162-036-02 65162-037-06 65162-036-06 65162-037-28 65162-037 65162-036 65162003728 65162003602 65162003603 65162003606 65162003706 65162003703 f1b3934b-1fc2-4ce8-9465-e1f031daf9c5 ad67e6fd-a68f-44db-9718-84a2cef86e09 |
Adverse event summaries are temporarily unavailable. Other product information remains available.